By Alistair Smout LONDON (Reuters) -A rise in the prevalence of COVID-19 infections in England in the latest week was driven by the dominant Delta variant rather than Omicron, Britain’s Office for National Statistics (ONS) said on Friday. There have been 134 confirmed cases of the Omicron variant in Britain, which has mutations consistent with …
England’s COVID-19 prevalence rises, led by Delta not Omicron Read More »
LONDON (Reuters) -Health officials in Britain said on Friday they were investigating a rise this week in the number of COVID-19 tests results that have a trait that is associated with the newly identified Omicron coronavirus variant of concern. One of Omicron’s mutations produces S-gene target failure (SGTF) in about half the PCR tests in …
UK officials say investigating possible increase in Omicron cases this week Read More »
LONDON (Reuters) – All members of Yorkshire’s coaching team have left, including director of cricket Martyn Moxon and coach Andrew Gale, the club said on Friday as it vowed to regain trust and rebuild after being rocked by allegations of institutional racism. First team coach and former captain Gale was suspended last month as part …
Cricket-Yorkshire say all members of coaching team have left the club Read More »
PARIS (Reuters) -French biotech firm Valneva said on Friday no conclusions should be drawn on the effectiveness of its COVID-19 vaccine by a British study, which found it was the only shot out of seven that offered no immunity boost when given to people previously immunized with Pfizer’s vaccine. Shares in Valneva fell by up …
Valneva says no conclusions should be drawn on its vaccine from UK booster study Read More »
By Alistair Smout LONDON (Reuters) – COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a new British study has found. The “COV-Boost” study was cited by British officials when they announced that Pfizer and Moderna were preferred …
UK study finds mRNA COVID-19 vaccines provide biggest booster impact Read More »
By Luc Cohen NEW YORK (Reuters) – Ghislaine Maxwell’s sex abuse trial in Manhattan federal court began this week. Prosecutors have accused the British socialite of grooming teenage girls for abuse by now-deceased investor Jeffrey Epstein. Maxwell has pleaded not guilty. Here are five key moments from the first week of trial: – In her …
Key moments from the first week of Ghislaine Maxwell’s sex abuse trial Read More »
By Alan Baldwin LONDON (Reuters) -Mercedes Formula One boss Toto Wolff is to meet survivors of the Grenfell Tower fire after apologising on behalf of his team on Friday for any distress caused by a sponsorship deal with a company linked to the 2017 disaster. The deal with Kingspan, an Irish company that produces high-performance …
Motor racing-Mercedes F1 team boss to meet Grenfell survivors Read More »
LONDON (Reuters) – Britain on Friday reported 50,584 further cases of COVID-19 and 143 more deaths within 28 days of a positive test, according to official data. That compares with 53,945 cases and 141 deaths reported a day earlier. (Reporting by Andrew MacAskill, Editing by Alistair Smout)
LONDON (Reuters) – Britain said on Friday there were still significant gaps between its position and the European Union over post-Brexit trade arrangements for Northern Ireland and it was ready to take unilateral action if needed. “The gap between our positions is still significant and progress on many issues has been quite limited,” Britain’s Brexit …
Significant gaps still remain after EU talks, UK’s Frost says Read More »
BRUSSELS (Reuters) – European Commission Vice-President Maros Sefcovic urged London on Friday to conclude a deal to allow medicines to flow easily from Britain to Northern Ireland as well as other issues concerning trade to the British province. “Time to get medicines across the finish line and show strong political will to advance on the …
EU’s Sefcovic urges Britain to conclude medicines deal for N. Ireland Read More »
